BioSpace News Archive

QOL Medical, LLC announced today it has selected Optum Frontier Therapies as its new pharmacy partner to support CSID patients nationwide being treated with Sucraid® (sacrosidase) Oral Solution.

Integrity Implants Inc. d/b/a Accelus and CHP Merger Corp. announced that the companies have mutually agreed to terminate, effective immediately, the previously announced business combination agreement dated November 14, 2021 as a result of market conditions.

Milestone Pharmaceuticals Inc. today announced that Milestone’s Compensation Committee granted one new employee 65,000 incentive stock options at a per share exercise price of $6.85.

The biobanking market has been estimated to experience novel growth opportunities in the forthcoming years.

In an increasingly glamour-conscious world, ablative skin resurfacing is fast gaining prominence.

Albany NY, United States: Atherosclerotic plaques form into coronary arteries and vein grafts causing coronary heart diseases.

DUBAI, United Arab Emirates, 30-50% of consumers prefer using at-home diagnostics for various conditions, and global self-testing kits market revenues are set to grow 2x by 2030 – these are the findings of a new study by Future Market Insights.

HRH is Only Hospital in Hudson County with Any SRC Accreditation.

Palantir Technologies Inc. (NYSE:PLTR) today announced an extension and expansion of its work with the U.S. Centers for Disease Control and Prevention (CDC) through the outbreak response and disease surveillance solution for the Data Collation and Integration for Public Health Event Response (DCIPHER) Program.

Catalent today announced that it will release financial results for the third quarter of fiscal year 2022 ended March 31, 2022, before the market open on Tuesday, May 3, 2022.